Search

Author/Creator Fritzell, Sara

1. 851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody. (10th December 2020)

Authors:
Nelson, Michelle; Miller, Robert; Nilsson, Anneli; Ljung, Lill; Chunyk, Allison; McMahan, Catherine; Bienvenue, David; Askmyr, Maria; Hernandez-Hoyos, Gabriela; Fritzell, Sara
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A507
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 851 Potent tumor-directed T cell activation and in vivo tumor inhibition induced by a 4–1BB x 5T4 ADAPTIR™ bispecific antibody. (9th November 2020)

Authors:
Nelson, Michelle; Miller, Robert; Nilsson, Anneli; Ljung, Lill; Chunyk, Allison; McMahan, Catherine; Bienvenue, David; Askmyr, Maria; Hernandez-Hoyos, Gabriela; Fritzell, Sara
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation. Issue 1 (11th April 2019)

Authors:
Kvarnhammar, Anne Månsson; Veitonmäki, Niina; Hägerbrand, Karin; Dahlman, Anna; Smith, Karin Enell; Fritzell, Sara; von Schantz, Laura; Thagesson, Mia; Werchau, Doreen; Smedenfors, Kristine; Johansson, Maria; Rosén, Anna; Åberg, Ida; Winnerstam, Magnus; Nyblom, Eva; Barchan, Karin; Furebring, Chr...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗